Wayne Hall

TL;DR: The title of this editorial evokes the image of a patient with a psychosis, usually schizo phrenia, who abuses or is dependent upon alcohol or an illicit drug.

TL;DR: In a sample of cannabis users referred for treatment, wide-ranging substance use was associated with elevated risk on measures of cannabis dependence, co-morbid psychopathology, and dysfunctional cannabis cognitions, have implications for cognitive-behavioral assessment and treatment.

TL;DR: In this article, an overall summative evaluation that draws on all the Better Access evaluation components, and other relevant information such as the better access post-implementation review, is presented to determine the extent to which Better Access has achieved its objectives and has been an effective response to the need for primary mental health treatment for people with common mental disorders.

TL;DR: The evidence base for some commonly accepted assumptions among bioethicists about the prevalence of neuroenhancement among college students and the degree to which putative neuroenhancers in fact enhance cognitive functioning are questioned.

TL;DR: The evidence suggests that common factors do not explain the comorbidity between cannabis use and psychosis, and it is unlikely that cannabis use causes psychosis among persons who would otherwise not have developed the disorder.